TARGETED DEAMINASE AND BASE EDITING USING SAME
Abstract:
The present invention relates to a cytosine or adenine deaminase in an isolated form or a variant thereof, a non-toxic full-length cytosine deaminase or a variant thereof, a fusion protein comprising same, a composition for base editing, and a method for editing a base by using same.
Information query
Patent Agency Ranking
0/0